Pertinax provides sustained, controlled antimicrobial protection for medical devices, biomaterials and in topical formulations.
Pertinax Pharma are supported by an experienced management team and a highly skilled and versatile team of scientists.
Get in touch to learn more about our technology and to discuss how Pertinax might be used in your products.
Get In Touch
About Pertinax Pharma
Pertinax formed in 2015, as a spin-out from the University of Bristol. The technology was initially developed in the laboratory of Dr Michele Barbour, CEO. Michele is supported by an experienced management team and a dynamic and dedicated team of scientists.
Find out the latest news and information from Pertinax.
Our fabulous Senior Development Scientist Alex was interviewed recently about life at Pertinax. Find out what she had to say about our activities, challenges and aspirations here! … Read More about Alex Hill spills the Pertinax beans!
To read our case study, click here! … Read More about We are delighted to have been featured as a SetSquared case study!
Pertinax Pharma are delighted to announce that they have secured funding from Innovation 4 Growth (I4G). I4G is a funding scheme managed by the University of the West of England and developed using the European Regional Development Fund. It … Read More about Pertinax awarded ERDF Innovation 4 Growth grant